Zeprumetostat (EZH2 Inhibitor) Approved by NMPA—Hengrui Pharma Advances R/R PTCL Treatment Innovation
The National Medical Products Administration (NMPA) has officially approved Zeprumetostat Tablets (brand name: Airuijing, development…
Articles
AI in Innovative Drug Development: A New Turning Point in the Global Pharmaceutical Industry
As Artificial Intelligence (AI) continues to evolve, the global pharmaceutical industry is undergoing a profound…
FDA Innovative Drugs 2025: Rare-Disease Therapies, Antibody Breakthroughs, and Global Innovation Momentum
The U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) continues…
From Quantity to Quality: China Pharmaceutical Innovation Enters a Golden Decade
Over the past decade, China pharmaceutical innovation has moved from “follower” to “parallel runner” and…
Chinese Biotech Soars: Innovent’s $11.4 Billion Takeda Deal Leads Historic Global Breakthrough
DengYue Medicine — Chinese biotech soars to new heights as Innovent Biologics announces a landmark…
China Medicine Wholesale Distributor Leads Global Expansion Via The Belt and Road Initiative
As China’s healthcare industry continues to evolve, China medicine wholesale distributors are stepping beyond domestic…
Why Green Strategy Is the New Growth Engine for China Drug Wholesale Distributors
For China drug wholesale distributors, sustainability is no longer just a slogan; it has become…
Pharmaceutical Distributors in China丨The Strategic Force Behind the Global Expansion of Innovative Drugs
Over the past decade, China has transformed from a producer of generics into a rising…
The Pharmaceutical Distribution Ecosystem: A Primer for China Licensed Wholesale Dealers
In recent years, China has become a key player in the global pharmaceutical supply chain.…
Drug Wholesalers in China—Connecting the Top 10 Chinese Pharmaceutical Companies to Global Markets
In recent years, China’s pharmaceutical industry has witnessed tremendous growth, evolving from a generic manufacturing…